GO:0036431 dCMP kinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036431 (dCMP kinase activity) catalyzes the reversible phosphorylation of dCMP to dCDP using ATP, a critical step in de novo and salvage pyrimidine deoxyribonucleotide biosynthesis [1, 4].
• The reaction is magnesium-dependent; Mg2+ acts as an essential cofactor by complexing with ATP and stabilizing the transition state [1, 4].
• Enzymes with dCMP kinase activity belong to the nucleoside monophosphate kinase (NMPK) family, including UMP-CMP kinase (CMPK1) and mitochondrial CMPK2, which exhibit broad substrate specificity toward pyrimidine nucleotides [6, 7, 8].
• Altered dCMP kinase activity has been linked to sickle cell erythrocyte abnormalities and cancer cell sensitivity to antimetabolite inhibitors [3, 6].
• CMPK2 functions as a metabolic rheostat in macrophage homeostasis, influencing inflammatory responses and mitochondrial function.
• Precise quantification of dCMP kinase activity requires careful control of Mg2+ concentrations, as adenylate-driven equilibration of deoxyribonucleotides is under magnesium control.
Description
dCMP kinase activity (GO:0036431) is a molecular function defined as the catalysis of the reaction ATP + dCMP = ADP + dCDP. This enzymatic step is essential for the salvage and interconversion of pyrimidine deoxyribonucleotides, providing the immediate precursor dCDP for DNA synthesis and repair. Researchers studying nucleotide metabolism, cancer chemoresistance, and mitochondrial dysfunction frequently encounter this activity because it sits at the crossroads of adenylate and non-adenylate nucleotide pools [1, 4]. The reaction is reversible and strongly influenced by cellular magnesium status, which modulates the equilibrium between ribo- and deoxyribonucleotides. Understanding dCMP kinase activity is therefore fundamental for dissecting how cells maintain dNTP balance, respond to genotoxic stress, and adapt to metabolic perturbations [6, 7].
dCMP kinase activity At A Glance
| GO ID | GO:0036431 |
|---|---|
| GO term | dCMP kinase activity |
| Ontology | molecular_function |
| Synonym | ATP:dCMP phosphotransferase activity |
| Definition | Catalysis of the reaction: ATP + dCMP = ADP + dCDP. |
| Major function | Phosphorylation of dCMP to dCDP in pyrimidine deoxyribonucleotide metabolism |
| Cofactor | Magnesium ions (Mg2+) |
| Reversibility | Reversible reaction |
| Related enzymes | UMP-CMP kinase (CMPK1), mitochondrial CMPK2 |
What Is GO:0036431?
dCMP kinase activity (GO:0036431) is the catalytic activity that transfers a phosphate group from ATP to deoxycytidine monophosphate (dCMP), yielding ADP and deoxycytidine diphosphate (dCDP). This activity belongs to the nucleoside monophosphate kinase family and is synonymous with ATP:dCMP phosphotransferase activity. It requires magnesium ions as cofactors and operates reversibly, contributing to the equilibration of pyrimidine deoxynucleotide pools [1, 4].
Why Is dCMP kinase activity Important in Cell Biology?
dCMP kinase activity is critical for maintaining the balance of deoxyribonucleotide triphosphates (dNTPs) required for DNA replication and repair. Dysregulation of this activity can lead to nucleotide pool imbalances, which are associated with increased mutagenesis, chemoresistance, and mitochondrial dysfunction [6, 7]. In sickle cell disease, decreased pyrimidine nucleoside monophosphate kinase activity has been observed, suggesting a role in erythrocyte pathology. Moreover, the magnesium-dependent nature of the reaction links cellular energetics to nucleotide homeostasis, making it a sensitive node for metabolic regulation [1, 4].
• Provides dCDP for DNA synthesis and repair, influencing genome stability.
• Contributes to pyrimidine salvage and interconversion pathways.
• Magnesium-dependent regulation connects adenylate energy status to deoxyribonucleotide pools [1, 4].
• Altered activity in sickle cell erythrocytes suggests a role in red blood cell disorders.
• CMPK2, a mitochondrial enzyme with dCMP kinase activity, acts as a rheostat in macrophage inflammation.
• Inhibition of CMPK and TMPK sensitizes chronic myeloid leukemia cells, highlighting therapeutic potential.
• Substrate promiscuity of UMP-CMP kinase affects both ribo- and deoxyribonucleotide pools.
• Reaction reversibility allows cells to buffer dCDP levels under metabolic stress.
• dCMP kinase activity is essential for mitochondrial DNA maintenance in some cell types.
• Quantitative understanding aids in modeling antimetabolite drug effects.
What Happens During dCMP kinase activity?
Substrate Binding and Magnesium Coordination
In simple terms: The enzyme grabs dCMP and ATP, using magnesium to hold them in place.
The reaction begins with the binding of dCMP and ATP to the active site of a nucleoside monophosphate kinase. Magnesium ions (Mg2+) are essential cofactors that coordinate with the phosphate groups of ATP and dCMP, neutralizing negative charges and facilitating the transfer [1, 4]. The enzyme undergoes conformational changes to align the substrates for catalysis.
Phosphoryl Transfer
In simple terms: A phosphate group is moved from ATP to dCMP.
The catalytic step involves the transfer of the terminal phosphoryl group from ATP to the 5'-hydroxyl of dCMP, forming dCDP and ADP. This phosphoryl transfer is reversible and depends on the relative concentrations of substrates and products. The reaction is driven by the adenylate energy charge and is sensitive to Mg2+ availability.
Product Release and Equilibration
In simple terms: The products are released, and the reaction can go backward if needed.
After phosphoryl transfer, ADP and dCDP are released from the active site. Because the reaction is reversible, the enzyme can also catalyze the reverse reaction, converting dCDP and ADP back to dCMP and ATP. This reversibility allows the enzyme to participate in the equilibration of pyrimidine deoxyribonucleotide pools in response to cellular demands.
Integration with Nucleotide Metabolism
In simple terms: This reaction connects to the broader network of nucleotide synthesis.
dCMP kinase activity is integrated into both de novo and salvage pathways for pyrimidine deoxyribonucleotides. The dCDP produced can be further phosphorylated to dCTP, which is used in DNA synthesis. Alternatively, dCDP can be dephosphorylated to dCMP, feeding back into the salvage pathway. This integration ensures balanced dNTP pools for DNA replication and repair [6, 8].
Key Genes Involved in GO:0036431 dCMP kinase activity
The following genes encode enzymes with demonstrated or inferred dCMP kinase activity or are directly involved in the reaction pathway.
| Gene | Major Role | Research Relevance |
|---|---|---|
| CMPK1 | UMP-CMP kinase; phosphorylates dCMP and other pyrimidine monophosphates | Broad substrate specificity; target in cancer and antiviral research |
| CMPK2 | Mitochondrial CMPK; functions as a rheostat in macrophage homeostasis | Inflammation and mitochondrial metabolism |
| AK1 | Adenylate kinase 1; maintains adenylate energy charge | Indirectly affects dCMP kinase activity via ATP/ADP balance |
| AK2 | Adenylate kinase 2; mitochondrial adenylate kinase | Links mitochondrial energetics to nucleotide metabolism |
| AK3 | Adenylate kinase 3; mitochondrial GTP:AMP phosphotransferase | May influence dCMP kinase activity through GTP pools |
| AK4 | Adenylate kinase 4; mitochondrial | Role in energy homeostasis |
| AK5 | Adenylate kinase 5; brain-specific | Potential role in neuronal nucleotide metabolism |
| NME1 | Nucleoside diphosphate kinase A; transfers phosphate from ATP to NDPs | Can produce dCDP from dCMP indirectly |
| NME2 | Nucleoside diphosphate kinase B | Similar to NME1 |
| DCTD | dCMP deaminase; converts dCMP to dUMP | Competes with dCMP kinase for dCMP |
| TYMS | Thymidylate synthase; uses dUMP for dTMP synthesis | Indirectly linked to dCMP metabolism |
| TMPK | Thymidylate kinase; phosphorylates dTMP to dTDP | Parallel pathway for pyrimidine deoxynucleotides |
| RRM1 | Ribonucleotide reductase subunit M1; reduces NDPs to dNDPs | Provides dCDP from CDP |
| RRM2 | Ribonucleotide reductase subunit M2 | Regulates dNTP pools |
| NT5C | 5'-nucleotidase, cytosolic; dephosphorylates dCMP | Opposes dCMP kinase activity |
| NT5C2 | 5'-nucleotidase, cytosolic II | Involved in purine and pyrimidine salvage |
| SLC29A1 | Equilibrative nucleoside transporter 1; imports deoxycytidine | Supplies dCMP precursors |
| DCK | Deoxycytidine kinase; phosphorylates deoxycytidine to dCMP | Upstream of dCMP kinase |
How Is dCMP kinase activity Regulated?
dCMP kinase activity is regulated at multiple levels. Magnesium availability directly controls the reaction rate, as Mg2+ is required for substrate coordination and catalysis [1, 4]. The enzyme's expression levels vary across tissues and cell types; for example, CMPK2 is induced in macrophages under inflammatory conditions, acting as a metabolic rheostat. Post-translational modifications and allosteric regulation by nucleotides may also modulate activity, though specific mechanisms remain to be fully elucidated. Additionally, the balance between dCMP kinase and opposing enzymes such as dCMP deaminase and 5'-nucleotidases determines net dCDP production [3, 6].
dCMP kinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| CMPK1 | Cancer chemoresistance; nucleoside analog activation | KO and point-mutation in leukemia cell lines |
| CMPK2 | Macrophage inflammation; mitochondrial dysfunction | KO and overexpression in macrophages |
| NT5C | Sickle cell disease; nucleotide imbalance | Knock-in of patient mutations in erythroid cells |
| DCK | Drug sensitivity; pyrimidine salvage | Overexpression and KO in cancer cells |
| RRM1 | dNTP pool regulation; gemcitabine resistance | KO and knock-in in pancreatic cancer models |
Sickle Cell Disease and Erythrocyte Metabolism
Decreased pyrimidine nucleoside monophosphate kinase activity, which includes dCMP kinase activity, has been reported in sickle cell erythrocytes. This reduction may contribute to the altered nucleotide metabolism and shortened lifespan of sickle red blood cells, suggesting a link between dCMP kinase dysfunction and hematological pathology.
Cancer Chemoresistance and Antimetabolite Sensitivity
In chronic myeloid leukemia, glutathione levels determine vulnerability to inhibitors of CMPK and TMPK. Since CMPK1 exhibits dCMP kinase activity, targeting this enzyme may overcome chemoresistance. Furthermore, dCMP kinase activity influences the activation of nucleoside analogs used in cancer therapy, making it a potential biomarker for drug response.
Mitochondrial Dysfunction and Inflammation
CMPK2, a mitochondrial enzyme with dCMP kinase activity, functions as a rheostat for macrophage homeostasis. Dysregulation of CMPK2 alters mitochondrial DNA synthesis and inflammatory cytokine production, implicating dCMP kinase activity in innate immunity and inflammatory diseases.
From dCMP kinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does loss of CMPK1 affect dCDP levels and DNA synthesis? | CMPK1 knockout cell lines (e.g., HAP1, HeLa) |
| How do point mutations in the active site alter dCMP kinase activity? | CRISPR point-mutation knock-in of catalytic residues |
| Can overexpression of CMPK2 rescue mitochondrial defects? | CMPK2 overexpression in CMPK2-null macrophages |
| What is the impact of dCMP kinase activity on nucleoside analog sensitivity? | Tagged knock-in of CMPK1 for proteomics and drug assays |
| How does magnesium availability regulate dCMP kinase activity in vivo? | Inducible knockout of magnesium transporters combined with metabolomics [1, 4] |
| Does dCMP kinase activity influence inflammatory cytokine production? | CRISPR knockout of CMPK2 in primary macrophages |
How to Study the dCMP kinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Coupled enzyme assay | dCMP kinase activity in real time | Kinetic characterization of wild-type and mutant enzymes |
| LC-MS/MS metabolomics | Intracellular dCMP, dCDP, and dNTP levels | Assessing pathway flux and pool sizes |
| CRISPR knockout library screen | Gene essentiality and synthetic lethality | Identifying modifiers of dCMP kinase dependency |
| Radioactive tracer assay | Phosphoryl transfer rate | Measuring enzyme activity in cell lysates |
| X-ray crystallography | Three-dimensional structure of enzyme-substrate complex | Structure-guided inhibitor design |
| Western blot | Protein expression levels of CMPK1/CMPK2 | Validating knockout or overexpression |
| qRT-PCR | mRNA expression of nucleotide metabolism genes | Assessing transcriptional regulation |
| Seahorse assay | Mitochondrial respiration and glycolysis | Linking dCMP kinase activity to cellular energetics |
Enzymatic Assays for dCMP Kinase Activity
Direct measurement of dCMP kinase activity typically uses coupled enzyme assays that monitor the conversion of dCMP to dCDP via absorbance or fluorescence. Radioactive tracer methods with 3H-dCMP or 32P-ATP provide high sensitivity. These assays require careful control of Mg2+ concentrations and pH to mimic physiological conditions [1, 4].
Metabolomics and Nucleotide Pool Analysis
Liquid chromatography-tandem mass spectrometry (LC-MS/MS) enables quantification of dCMP, dCDP, and other nucleotides in cell extracts. This approach reveals how genetic perturbations or drug treatments affect dCMP kinase activity in the context of overall dNTP pools. Stable isotope labeling can trace flux through the pathway [4, 6].
Genetic Screens and CRISPR Libraries
CRISPR knockout libraries targeting nucleotide metabolism genes can identify synthetic lethal interactions with dCMP kinase inhibition. Pooled screens coupled with next-generation sequencing reveal genes that modulate sensitivity to antimetabolites. Bioinformatics analysis of screen data pinpoints pathways that compensate for loss of dCMP kinase activity.
Structural and Biophysical Methods
X-ray crystallography and cryo-electron microscopy of CMPK1 and CMPK2 provide atomic-level insights into substrate binding and catalysis. Isothermal titration calorimetry and surface plasmon resonance measure binding affinities for dCMP and ATP analogs. These methods guide the design of specific inhibitors.
How CRISPR Can Be Used to Study GO:0036431 dCMP kinase activity
Knockout
CRISPR-Cas9 knockout of CMPK1 or CMPK2 eliminates dCMP kinase activity, allowing researchers to study its role in dNTP pool maintenance, DNA replication, and drug sensitivity. Knockout cell lines can be validated by sequencing and enzymatic assays, and then subjected to metabolomic profiling [6, 7].
Point Mutation
Introducing specific point mutations in the catalytic domain of CMPK1 (e.g., aspartate to alanine) via CRISPR base editing or homology-directed repair can dissect the contribution of individual residues to dCMP kinase activity. Such models help distinguish catalytic activity from non-catalytic functions.
Knock-in
Knock-in of epitope tags (e.g., FLAG, HA) or fluorescent proteins at the endogenous CMPK1 or CMPK2 locus enables real-time tracking of protein localization and interaction partners. Knock-in of disease-associated mutations can model altered dCMP kinase activity in a physiological context [3, 7].
Overexpression
CRISPR activation (CRISPRa) or lentiviral overexpression of CMPK1/CMPK2 increases dCMP kinase activity, which can rescue phenotypes caused by nucleotide depletion or mitochondrial stress. Overexpression models are useful for testing whether increased activity promotes chemoresistance or inflammatory responses [6, 7].
How EDITGENE Supports dCMP kinase activity Research
Researchers studying dCMP kinase activity-related genes often need to determine whether a candidate gene is causally involved in nucleotide metabolism, disease progression, or drug response. EDITGENE provides a comprehensive suite of CRISPR-based services to generate precisely engineered cell models, enabling rigorous functional validation of dCMP kinase activity and its regulatory network.
Contact EDITGENE today to design your custom CRISPR model for dCMP kinase activity research.
Frequently Asked Questions About dCMP kinase activity
What is dCMP kinase activity?
dCMP kinase activity (GO:0036431) is the enzymatic catalysis of the reaction ATP + dCMP = ADP + dCDP, a key step in pyrimidine deoxyribonucleotide metabolism.
What genes are involved in dCMP kinase activity?
Genes encoding enzymes with this activity include CMPK1 (UMP-CMP kinase) and CMPK2 (mitochondrial CMPK), as well as adenylate kinases that influence ATP/ADP balance [7, 8].
What is the role of magnesium in dCMP kinase activity?
Magnesium ions (Mg2+) are essential cofactors that coordinate with ATP and dCMP, stabilizing the transition state and enabling phosphoryl transfer [1, 4].
How is dCMP kinase activity measured?
It is measured using coupled enzyme assays, radioactive tracer methods, or LC-MS/MS metabolomics to quantify dCDP production [1, 4].
What diseases are associated with dCMP kinase activity?
Altered activity has been linked to sickle cell disease, cancer chemoresistance, and mitochondrial dysfunction in macrophages [3, 6, 7].
What is the difference between CMPK1 and CMPK2?
CMPK1 is a cytosolic UMP-CMP kinase with broad substrate specificity, while CMPK2 is mitochondrial and functions as a metabolic rheostat in inflammation [7, 8].
Can dCMP kinase activity be inhibited therapeutically?
Inhibitors of CMPK and TMPK have shown promise in sensitizing chronic myeloid leukemia cells, suggesting therapeutic potential.
How does dCMP kinase activity affect DNA synthesis?
By producing dCDP, which is phosphorylated to dCTP, it provides a direct precursor for DNA replication and repair.
What are the research methods to study dCMP kinase activity?
Common methods include CRISPR knockout screens, enzymatic assays, metabolomics, and structural biology techniques like X-ray crystallography [6, 8].
Is dCMP kinase activity reversible?
Yes, the reaction is reversible, allowing the enzyme to buffer dCDP levels depending on cellular energy status.
Conclusion
dCMP kinase activity (GO:0036431) is a fundamental enzymatic function that bridges adenylate energetics and pyrimidine deoxyribonucleotide metabolism. Its magnesium-dependent, reversible nature positions it as a sensitive node for cellular adaptation to metabolic stress. Dysregulation of this activity contributes to hematological disorders, cancer chemoresistance, and inflammatory diseases, making it a compelling target for therapeutic intervention and biomarker discovery [1, 3, 4, 6, 7]. Continued research using advanced CRISPR models and metabolomic profiling will further illuminate its mechanistic roles and translational potential.
References
- 1. Kleczkowski LA et al.. 2023. Magnesium and cell energetics: At the junction of metabolism of adenylate and non-adenylate nucleotides.. J Plant Physiol 280:153901 PMID: 36549033
- 2. Meinsma R et al.. 2016. Purification, activity, and expression levels of two uridine-cytidine kinase isoforms in neuroblastoma cell lines.. Nucleosides Nucleotides Nucleic Acids 35(10-12):613-618 PMID: 27906629
- 3. Zerez CR et al.. 1992. Decreased pyrimidine nucleoside monophosphate kinase activity in sickle erythrocytes.. Blood 80(2):512-6 PMID: 1320957
- 4. Kleczkowski LA et al.. 2025. Adenylate-driven equilibration of both ribo- and deoxyribonucleotides is under magnesium control: Quantification of the Mg(2+)-signal.. J Plant Physiol 304:154380 PMID: 39709740
- 5. Lange PR et al.. 2008. Functions of chloroplastic adenylate kinases in Arabidopsis.. Plant Physiol 146(2):492-504 PMID: 18162585
- 6. Huang CY et al.. 2024. Glutathione determines chronic myeloid leukemia vulnerability to an inhibitor of CMPK and TMPK.. Commun Biol 7(1):843 PMID: 38987326
- 7. Arumugam P et al.. 2022. The mitochondrial gene-CMPK2 functions as a rheostat for macrophage homeostasis.. Front Immunol 13:935710 PMID: 36451821
- 8. Pearman AT et al.. 2001. Characterization of human UMP-CMP kinase enzymatic activity and 5' untranslated region.. Life Sci 69(20):2361-70 PMID: 11681623
